The drug discovery and development landscape is being rapidly transformed by artificial intelligence. From target identification to clinical trials, the promise of AI lies in its ability to accelerate research, reduce costs, and increase success rates. However, a significant barrier remains: the lack of high-quality, AI-ready data. Without a unified, clean, and contextualized data foundation, the power of AI, machine learning, and Generative AI cannot be fully realized.

At Elucidata, we help biopharma teams overcome this challenge by making their biomedical data AI-ready at scale. Our platform streamlines the entire data lifecycle, from ingestion and harmonization to analysis and application. We empower R&D teams to turn messy, siloed data into a structured asset that fuels their AI-driven initiatives and accelerates the entire pipeline.

Meet our Co-Founder & CTO, Swetabh Pathak at the AI Drug Discovery & Development Summit to learn how we are solving one of the biggest bottlenecks in drug development: getting biomedical data clean, contextualized, and AI-ready for groundbreaking discoveries.